Oscar Health, Inc.
NYSEOSCR enters the second week of June having done something most health insurance stocks have failed to do this year — rally 29% in a month — and now faces the question of whether the Street's belated conviction can survive a price that has already sprinted past most targets. The catalyst crystallising that tension arrived this morning. Barclays upgraded OSCR to Overweight from…
OSCR short interest fell 24.9% over the past week to 7.35% of float, as short sellers unwound positions ahead of earnings. Cost to borrow collapsed 67.2% to 0.62% — near multi-month lows — while availability surged 76% to 8,878%, signaling abundant borrow supply and easing pressure on shorts.
Snapshot as of 22 Jun 2026
OSCR enters the second week of June having done something most health insurance stocks have failed to do this year — rally 29% in a month — and now faces the question of whether the Street's belated conviction can…
OSCR just reported the quarter, and the numbers tell two different stories depending on where you look. Q1 2026 EPS came in at $2.07, more than double the $1.01 consensus estimate. Revenue of $4.65 billion was a 53%…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OSCR — free to start on ORTEX.
Sign up for free →Open OSCR on ORTEX